Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Cell Transplantation (HCT)”

227 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 227 results

Testing effectiveness (Phase 2)Study completedNCT03128359
What this trial is testing

High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

Who this might be right for
Acute LeukemiaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center 38
Post-approval studies (Phase 4)UnknownNCT02662374
What this trial is testing

Oral Hygiene Regimen in Patients on HCT

Who this might be right for
Oral Mucositis
Riyadh Colleges of Dentistry and Pharmacy 45
Not applicableLooking for participantsNCT06941389
What this trial is testing

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease (SCD)
University of Rochester 480
Post-approval studies (Phase 4)Study completedNCT00361140
What this trial is testing

Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)

Who this might be right for
Myelodysplastic SyndromesMyeloproliferative DisordersLeukemia, Lymphocytic+2 more
H. Lee Moffitt Cancer Center and Research Institute 72
Testing effectiveness (Phase 2)Ended earlyNCT04849910
What this trial is testing

Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Vor Biopharma 67
Early research (Phase 1)Ended earlyNCT04239989
What this trial is testing

Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant

Who this might be right for
Bronchiolitis Obliterans
M.D. Anderson Cancer Center 8
Not applicableStudy completedNCT03328663
What this trial is testing

Psychological Intervention for Caregivers of Patients Undergoing Stem Cell Transplant

Who this might be right for
Cancer
Massachusetts General Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT07359859
What this trial is testing

Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

Who this might be right for
Hematologic Malignancies
Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT03518203
What this trial is testing

Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
Thrombotic MicroangiopathiesAtypical Hemolytic Uremic SyndromeMultiple Organ Dysfunction Syndrome
Children's Hospital Medical Center, Cincinnati 23
Early research (Phase 1)Looking for participantsNCT07302776
What this trial is testing

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

Who this might be right for
GVHDHematopoietic Cell Transplantation (HCT)Acute Myeloid Leukemia (AML)+4 more
Stanford University 50
Testing effectiveness (Phase 2)Looking for participantsNCT07046078
What this trial is testing

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

Who this might be right for
Acute Leukemia of Ambiguous LineageAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia+1 more
Fred Hutchinson Cancer Center
Post-approval studies (Phase 4)Study completedNCT00654589
What this trial is testing

Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload

Who this might be right for
Iron Overload
Novartis Pharmaceuticals 75
Not applicableStudy completedNCT02194439
What this trial is testing

Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease

Who this might be right for
Graft-Versus-Host Disease
Indiana University 415
Not applicableStudy completedNCT04342442
What this trial is testing

Identification of Novel Targetable Kinases in SR-a GvHD

Who this might be right for
Graft Versus Host Disease
University of Freiburg 24
Early research (Phase 1)Study completedNCT03315741
What this trial is testing

The Safety and Tolerability of Pirfenidone for BOS After HCT

Who this might be right for
Bronchiolitis ObliteransGraft Vs Host Disease
Stanford University 30
Not applicableNot Yet RecruitingNCT07762508
What this trial is testing

VABu Conditioning Regimen in Allo-HSCT for AML Patients

Who this might be right for
Leukemia, Myeloid, Acute(AML)Hematopoietic Stem Cell Transplantation (HSCT)
The First Affiliated Hospital of Soochow University 42
Testing effectiveness (Phase 2)Temporarily pausedNCT03728335
What this trial is testing

Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 Mutation

Who this might be right for
Acute Myeloid Leukemia
City of Hope Medical Center 35
Testing effectiveness (Phase 2)Ended earlyNCT01582048
What this trial is testing

Multicenter Study of Peritransplantation Immunosuppression for Mismatched Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

Who this might be right for
Patients Receiving Mismatched Allogeneic HCT
Prof. Dr. med. Wolfgang Bethge 9
Testing effectiveness (Phase 2)Study completedNCT02145403
What this trial is testing

Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesRelapseGraft-Versus-Host Disease
University of Michigan Rogel Cancer Center 53
Large-scale testing (Phase 3)Study completedNCT00774527
What this trial is testing

Comparison of Cy-Atg Vs Cy-Flu-Atg for the Conditioning Therapy in Allo-HCT

Who this might be right for
Bone Marrow Failure Syndromes
Cooperative Study Group A for Hematology 82
Next Page
20